 | • レポートコード：MRC2102QY14978 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、140ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界のトロンビン（ヒト）市場について種類別（500IU /バイアル、1000IU /バイアル、2500IU /バイアル）、用途別（バイオテクノロジー、医療、微生物、その他）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・トロンビン（ヒト）市場の概要 ・世界の主要地域別トロンビン（ヒト）市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のトロンビン（ヒト）市場規模2015-2026：種類別（500IU /バイアル、1000IU /バイアル、2500IU /バイアル） ・世界のトロンビン（ヒト）市場規模2015-2026：用途別（バイオテクノロジー、医療、微生物、その他） ・トロンビン（ヒト）の米国市場規模2015-2020 ・トロンビン（ヒト）のヨーロッパ市場規模2015-2020 ・トロンビン（ヒト）の中国市場規模2015-2020 ・トロンビン（ヒト）の日本市場規模2015-2020 ・トロンビン（ヒト）の東南アジア市場規模2015-2020 ・トロンビン（ヒト）のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・トロンビン（ヒト）の製造コスト分析 ・販売チャネル、流通業者、顧客 ・トロンビン（ヒト）の市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Thrombin (Human) Market
The global Thrombin (Human) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Thrombin (Human) Scope and Market Size
The global Thrombin (Human) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Thrombin (Human) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Thrombin (Human) market is segmented into
500IU/Vial
1000IU/Vial
2500IU/Vial
Segment by Application, the Thrombin (Human) market is segmented into
Biotechnology
Medicine
Microbiology
Other
The Thrombin (Human) market is analysed and market size information is provided by regions (countries). Segment by Application, the Thrombin (Human) market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Thrombin (Human) Market Share Analysis
Thrombin (Human) market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Thrombin (Human) business, the date to enter into the Thrombin (Human) market, Thrombin (Human) product introduction, recent developments, etc.
The major vendors covered:
Baxter
AMRESCO Inc
BD Biosciences
Life Technologies Corporation
PromoCell GmbH
Sigma-Aldrich Corporation
Vitrolife AB
CSL
Bayer
Grifols
Octapharma
Shanghai RAAS
Hualan Biological
1 Thrombin (Human) Market Overview
1.1 Thrombin (Human) Product Scope
1.2 Thrombin (Human) Segment by Type
1.2.1 Global Thrombin (Human) Sales by Type (2020-2026)
1.2.2 500IU/Vial
1.2.3 1000IU/Vial
1.2.4 2500IU/Vial
1.3 Thrombin (Human) Segment by Application
1.3.1 Global Thrombin (Human) Sales Comparison by Application (2020-2026)
1.3.2 Biotechnology
1.3.3 Medicine
1.3.4 Microbiology
1.3.5 Other
1.4 Thrombin (Human) Market Estimates and Forecasts (2015-2026)
1.4.1 Global Thrombin (Human) Sales Growth Rate (2015-2026)
1.4.2 Global Thrombin (Human) Revenue and Growth Rate (2015-2026)
1.4.3 Global Thrombin (Human) Price Trends (2015-2026)
2 Thrombin (Human) Estimate and Forecast by Region
2.1 Global Thrombin (Human) Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Thrombin (Human) Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Thrombin (Human) Sales Market Share by Region (2015-2020)
2.2.2 Global Thrombin (Human) Revenue Market Share by Region (2015-2020)
2.3 Global Thrombin (Human) Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Thrombin (Human) Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Thrombin (Human) Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Thrombin (Human) Estimates and Projections (2015-2026)
2.4.2 Europe Thrombin (Human) Estimates and Projections (2015-2026)
2.4.3 China Thrombin (Human) Estimates and Projections (2015-2026)
2.4.4 Japan Thrombin (Human) Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Thrombin (Human) Estimates and Projections (2015-2026)
2.4.6 India Thrombin (Human) Estimates and Projections (2015-2026)
3 Global Thrombin (Human) Competition Landscape by Players
3.1 Global Top Thrombin (Human) Players by Sales (2015-2020)
3.2 Global Top Thrombin (Human) Players by Revenue (2015-2020)
3.3 Global Thrombin (Human) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Thrombin (Human) as of 2019)
3.4 Global Thrombin (Human) Average Price by Company (2015-2020)
3.5 Manufacturers Thrombin (Human) Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Thrombin (Human) Players (Opinion Leaders)
4 Global Thrombin (Human) Market Size by Type
4.1 Global Thrombin (Human) Historic Market Review by Type (2015-2020)
4.1.1 Global Thrombin (Human) Sales Market Share by Type (2015-2020)
4.1.2 Global Thrombin (Human) Revenue Market Share by Type (2015-2020)
4.1.3 Global Thrombin (Human) Price by Type (2015-2020)
4.2 Global Thrombin (Human) Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Thrombin (Human) Sales Forecast by Type (2021-2026)
4.2.2 Global Thrombin (Human) Revenue Forecast by Type (2021-2026)
4.2.3 Global Thrombin (Human) Price Forecast by Type (2021-2026)
5 Global Thrombin (Human) Market Size by Application
5.1 Global Thrombin (Human) Historic Market Review by Application (2015-2020)
5.1.1 Global Thrombin (Human) Sales Market Share by Application (2015-2020)
5.1.2 Global Thrombin (Human) Revenue Market Share by Application (2015-2020)
5.1.3 Global Thrombin (Human) Price by Application (2015-2020)
5.2 Global Thrombin (Human) Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Thrombin (Human) Sales Forecast by Application (2021-2026)
5.2.2 Global Thrombin (Human) Revenue Forecast by Application (2021-2026)
5.2.3 Global Thrombin (Human) Price Forecast by Application (2021-2026)
6 United States Thrombin (Human) Market Facts & Figures
6.1 United States Thrombin (Human) Sales Market Share by Company (2015-2020)
6.2 United States Thrombin (Human) Sales Market Share by Type (2015-2020)
6.3 United States Thrombin (Human) Sales Market Share by Application (2015-2020)
7 Europe Thrombin (Human) Market Facts & Figures
7.1 Europe Thrombin (Human) Sales Market Share by Company (2015-2020)
7.2 Europe Thrombin (Human) Sales Market Share by Type (2015-2020)
7.3 Europe Thrombin (Human) Sales Market Share by Application (2015-2020)
8 China Thrombin (Human) Market Facts & Figures
8.1 China Thrombin (Human) Sales Market Share by Company (2015-2020)
8.2 China Thrombin (Human) Sales Market Share by Type (2015-2020)
8.3 China Thrombin (Human) Sales Market Share by Application (2015-2020)
9 Japan Thrombin (Human) Market Facts & Figures
9.1 Japan Thrombin (Human) Sales Market Share by Company (3015-3030)
9.2 Japan Thrombin (Human) Sales Market Share by Type (2015-2020)
9.3 Japan Thrombin (Human) Sales Market Share by Application (2015-2020)
10 Southeast Asia Thrombin (Human) Market Facts & Figures
10.1 Southeast Asia Thrombin (Human) Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Thrombin (Human) Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Thrombin (Human) Sales Market Share by Application (2015-2020)
11 India Thrombin (Human) Market Facts & Figures
11.1 India Thrombin (Human) Sales Market Share by Company (2015-2020)
11.2 India Thrombin (Human) Sales Market Share by Type (2015-2020)
11.3 India Thrombin (Human) Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Thrombin (Human) Business
12.1 Baxter
12.1.1 Baxter Corporation Information
12.1.2 Baxter Business Overview
12.1.3 Baxter Thrombin (Human) Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Baxter Thrombin (Human) Products Offered
12.1.5 Baxter Recent Development
12.2 AMRESCO Inc
12.2.1 AMRESCO Inc Corporation Information
12.2.2 AMRESCO Inc Business Overview
12.2.3 AMRESCO Inc Thrombin (Human) Sales, Revenue and Gross Margin (2015-2020)
12.2.4 AMRESCO Inc Thrombin (Human) Products Offered
12.2.5 AMRESCO Inc Recent Development
12.3 BD Biosciences
12.3.1 BD Biosciences Corporation Information
12.3.2 BD Biosciences Business Overview
12.3.3 BD Biosciences Thrombin (Human) Sales, Revenue and Gross Margin (2015-2020)
12.3.4 BD Biosciences Thrombin (Human) Products Offered
12.3.5 BD Biosciences Recent Development
12.4 Life Technologies Corporation
12.4.1 Life Technologies Corporation Corporation Information
12.4.2 Life Technologies Corporation Business Overview
12.4.3 Life Technologies Corporation Thrombin (Human) Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Life Technologies Corporation Thrombin (Human) Products Offered
12.4.5 Life Technologies Corporation Recent Development
12.5 PromoCell GmbH
12.5.1 PromoCell GmbH Corporation Information
12.5.2 PromoCell GmbH Business Overview
12.5.3 PromoCell GmbH Thrombin (Human) Sales, Revenue and Gross Margin (2015-2020)
12.5.4 PromoCell GmbH Thrombin (Human) Products Offered
12.5.5 PromoCell GmbH Recent Development
12.6 Sigma-Aldrich Corporation
12.6.1 Sigma-Aldrich Corporation Corporation Information
12.6.2 Sigma-Aldrich Corporation Business Overview
12.6.3 Sigma-Aldrich Corporation Thrombin (Human) Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Sigma-Aldrich Corporation Thrombin (Human) Products Offered
12.6.5 Sigma-Aldrich Corporation Recent Development
12.7 Vitrolife AB
12.7.1 Vitrolife AB Corporation Information
12.7.2 Vitrolife AB Business Overview
12.7.3 Vitrolife AB Thrombin (Human) Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Vitrolife AB Thrombin (Human) Products Offered
12.7.5 Vitrolife AB Recent Development
12.8 CSL
12.8.1 CSL Corporation Information
12.8.2 CSL Business Overview
12.8.3 CSL Thrombin (Human) Sales, Revenue and Gross Margin (2015-2020)
12.8.4 CSL Thrombin (Human) Products Offered
12.8.5 CSL Recent Development
12.9 Bayer
12.9.1 Bayer Corporation Information
12.9.2 Bayer Business Overview
12.9.3 Bayer Thrombin (Human) Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Bayer Thrombin (Human) Products Offered
12.9.5 Bayer Recent Development
12.10 Grifols
12.10.1 Grifols Corporation Information
12.10.2 Grifols Business Overview
12.10.3 Grifols Thrombin (Human) Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Grifols Thrombin (Human) Products Offered
12.10.5 Grifols Recent Development
12.11 Octapharma
12.11.1 Octapharma Corporation Information
12.11.2 Octapharma Business Overview
12.11.3 Octapharma Thrombin (Human) Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Octapharma Thrombin (Human) Products Offered
12.11.5 Octapharma Recent Development
12.12 Shanghai RAAS
12.12.1 Shanghai RAAS Corporation Information
12.12.2 Shanghai RAAS Business Overview
12.12.3 Shanghai RAAS Thrombin (Human) Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Shanghai RAAS Thrombin (Human) Products Offered
12.12.5 Shanghai RAAS Recent Development
12.13 Hualan Biological
12.13.1 Hualan Biological Corporation Information
12.13.2 Hualan Biological Business Overview
12.13.3 Hualan Biological Thrombin (Human) Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Hualan Biological Thrombin (Human) Products Offered
12.13.5 Hualan Biological Recent Development
13 Thrombin (Human) Manufacturing Cost Analysis
13.1 Thrombin (Human) Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Thrombin (Human)
13.4 Thrombin (Human) Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Thrombin (Human) Distributors List
14.3 Thrombin (Human) Customers
15 Market Dynamics
15.1 Thrombin (Human) Market Trends
15.2 Thrombin (Human) Opportunities and Drivers
15.3 Thrombin (Human) Market Challenges
15.4 Thrombin (Human) Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Thrombin (Human) Sales (K Units) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Thrombin (Human) Sales (K Units) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Thrombin (Human) Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Thrombin (Human) Sales (K Units) by Region (2015-2020)
Table 5. Global Thrombin (Human) Sales Market Share by Region (2015-2020)
Table 6. Global Thrombin (Human) Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Thrombin (Human) Revenue Share by Region (2015-2020)
Table 8. Global Thrombin (Human) Sales (K Units) Forecast by Region (2021-2026)
Table 9. Global Thrombin (Human) Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Thrombin (Human) Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Thrombin (Human) Revenue Share Forecast by Region (2021-2026)
Table 12. Global Thrombin (Human) (K Units) of Key Companies (2015-2020)
Table 13. Global Thrombin (Human) Sales Share by Company (2015-2020)
Table 14. Global Thrombin (Human) Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Thrombin (Human) Revenue Share by Company (2015-2020)
Table 16. Global Thrombin (Human) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Thrombin (Human) as of 2019)
Table 17. Global Thrombin (Human) Average Price (USD/Unit) of Key Company (2015-2020)
Table 18. Manufacturers Thrombin (Human) Manufacturing Sites and Area Served
Table 19. Manufacturers Thrombin (Human) Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Thrombin (Human) Players
Table 22. Global Thrombin (Human) Sales (K Units) by Type (2015-2020)
Table 23. Global Thrombin (Human) Sales Share by Type (2015-2020)
Table 24. Global Thrombin (Human) Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Thrombin (Human) Price (K Units) by Type (2015-2020)
Table 26. Global Thrombin (Human) Sales Share by Type (2021-2026)
Table 27. Global Thrombin (Human) Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Thrombin (Human) Revenue Share by Type (2021-2026)
Table 29. Global Thrombin (Human) Price (K Units) by Type (2021-2026)
Table 30. Global Thrombin (Human) Sales (K Units) by Application (2015-2020)
Table 31. Global Thrombin (Human) Sales Share by Application (2015-2020)
Table 32. Global Thrombin (Human) Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Thrombin (Human) Price (K Units) by Application (2015-2020)
Table 34. Global Thrombin (Human) Sales (K Units) by Application (2021-2026)
Table 35. Global Thrombin (Human) Sales Share by Application (2021-2026)
Table 36. Global Thrombin (Human) Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Thrombin (Human) Revenue Share by Application (2021-2026)
Table 38. Global Thrombin (Human) Price (K Units) by Application (2021-2026)
Table 39. United States Thrombin (Human) Sales (K Units) by Company (2015-2020)
Table 40. United States Thrombin (Human) Sales Market Share by Company (2015-2020)
Table 41. United States Thrombin (Human) Sales (K Units) by Type (2015-2020)
Table 42. United States Thrombin (Human) Sales Market Share by Type (2015-2020)
Table 43. United States Thrombin (Human) Sales (K Units) by Application (2015-2020)
Table 44. United States Thrombin (Human) Sales Market Share by Application (2015-2020)
Table 45. Europe Thrombin (Human) Sales (K Units) by Company (2015-2020)
Table 46. Europe Thrombin (Human) Sales Market Share by Company (2015-2020)
Table 47. Europe Thrombin (Human) Sales (K Units) by Type (2015-2020)
Table 48. Europe Thrombin (Human) Sales Market Share by Type (2015-2020)
Table 49. Europe Thrombin (Human) Sales (K Units) by Application (2015-2020)
Table 50. Europe Thrombin (Human) Sales Market Share by Type (2015-2020)
Table 51. China Thrombin (Human) Sales (K Units) by Company (2015-2020)
Table 52. China Thrombin (Human) Sales Market Share by Company (2015-2020)
Table 53. China Thrombin (Human) Sales (K Units) by Type (2015-2020)
Table 54. China Thrombin (Human) Sales Market Share by Type (2015-2020)
Table 55. China Thrombin (Human) Sales (K Units) by Application (2015-2020)
Table 56. China Thrombin (Human) Sales Market Share by Application (2015-2020)
Table 57. Japan Thrombin (Human) Sales (K Units) by Company (2015-2020)
Table 58. Japan Thrombin (Human) Sales Market Share by Company (2015-2020)
Table 59. Japan Thrombin (Human) Sales (K Units) by Type (2015-2020)
Table 60. Japan Thrombin (Human) Sales Market Share by Type (2015-2020)
Table 61. Japan Thrombin (Human) Sales (K Units) by Application (2015-2020)
Table 62. Japan Thrombin (Human) Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Thrombin (Human) Sales (K Units) by Company (2015-2020)
Table 64. Southeast Asia Thrombin (Human) Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Thrombin (Human) Sales (K Units) by Type (2015-2020)
Table 66. Southeast Asia Thrombin (Human) Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Thrombin (Human) Sales (K Units) by Type (2015-2020)
Table 68. Southeast Asia Thrombin (Human) Sales Market Share by Application (2015-2020)
Table 69. India Thrombin (Human) Sales (K Units) by Company (2015-2020)
Table 70. India Thrombin (Human) Sales Market Share by Company (2015-2020)
Table 71. India Thrombin (Human) Sales (K Units) by Type (2015-2020)
Table 72. India Thrombin (Human) Sales Market Share by Type (2015-2020)
Table 73. India Thrombin (Human) Sales (K Units) by Application (2015-2020)
Table 74. India Thrombin (Human) Sales Market Share by Application (2015-2020)
Table 75. Baxter Corporation Information
Table 76. Baxter Description and Business Overview
Table 77. Baxter Thrombin (Human) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Baxter Thrombin (Human) Product
Table 79. Baxter Recent Development
Table 80. AMRESCO Inc Corporation Information
Table 81. AMRESCO Inc Description and Business Overview
Table 82. AMRESCO Inc Thrombin (Human) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. AMRESCO Inc Thrombin (Human) Product
Table 84. AMRESCO Inc Recent Development
Table 85. BD Biosciences Corporation Information
Table 86. BD Biosciences Description and Business Overview
Table 87. BD Biosciences Thrombin (Human) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. BD Biosciences Thrombin (Human) Product
Table 89. BD Biosciences Recent Development
Table 90. Life Technologies Corporation Corporation Information
Table 91. Life Technologies Corporation Description and Business Overview
Table 92. Life Technologies Corporation Thrombin (Human) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Life Technologies Corporation Thrombin (Human) Product
Table 94. Life Technologies Corporation Recent Development
Table 95. PromoCell GmbH Corporation Information
Table 96. PromoCell GmbH Description and Business Overview
Table 97. PromoCell GmbH Thrombin (Human) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. PromoCell GmbH Thrombin (Human) Product
Table 99. PromoCell GmbH Recent Development
Table 100. Sigma-Aldrich Corporation Corporation Information
Table 101. Sigma-Aldrich Corporation Description and Business Overview
Table 102. Sigma-Aldrich Corporation Thrombin (Human) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Sigma-Aldrich Corporation Thrombin (Human) Product
Table 104. Sigma-Aldrich Corporation Recent Development
Table 105. Vitrolife AB Corporation Information
Table 106. Vitrolife AB Description and Business Overview
Table 107. Vitrolife AB Thrombin (Human) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Vitrolife AB Thrombin (Human) Product
Table 109. Vitrolife AB Recent Development
Table 110. CSL Corporation Information
Table 111. CSL Thrombin (Human) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. CSL Description and Business Overview
Table 113. CSL Thrombin (Human) Product
Table 114. CSL Recent Development
Table 115. Bayer Corporation Information
Table 116. Bayer Thrombin (Human) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Bayer Description and Business Overview
Table 118. Bayer Thrombin (Human) Product
Table 119. Bayer Recent Development
Table 120. Grifols Corporation Information
Table 121. Grifols Description and Business Overview
Table 122. Grifols Thrombin (Human) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. Grifols Thrombin (Human) Product
Table 124. Grifols Recent Development
Table 125. Octapharma Corporation Information
Table 126. Octapharma Description and Business Overview
Table 127. Octapharma Thrombin (Human) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Octapharma Thrombin (Human) Product
Table 129. Octapharma Recent Development
Table 130. Shanghai RAAS Corporation Information
Table 131. Shanghai RAAS Description and Business Overview
Table 132. Shanghai RAAS Thrombin (Human) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. Shanghai RAAS Thrombin (Human) Product
Table 134. Shanghai RAAS Recent Development
Table 135. Hualan Biological Corporation Information
Table 136. Hualan Biological Description and Business Overview
Table 137. Hualan Biological Thrombin (Human) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 138. Hualan Biological Thrombin (Human) Product
Table 139. Hualan Biological Recent Development
Table 140. Production Base and Market Concentration Rate of Raw Material
Table 141. Key Suppliers of Raw Materials
Table 142. Thrombin (Human) Distributors List
Table 143. Thrombin (Human) Customers List
Table 144. Thrombin (Human) Market Key Trends
Table 145. Thrombin (Human) Key Opportunities and Drivers
Table 146. Thrombin (Human) Market Challenges
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Thrombin (Human) Product Picture
Figure 2. Global Thrombin (Human) Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Thrombin (Human) Market Share by Application in 2020 & 2026
Figure 6. Biotechnology Examples
Figure 7. Medicine Examples
Figure 8. Microbiology Examples
Figure 9. Other Examples
Figure 10. Global Thrombin (Human) Sales (K Units) Growth Rate (2015-2026)
Figure 11. Global Thrombin (Human) Revenue (US$ Million) Growth Rate (2015-2026)
Figure 12. Global Thrombin (Human) Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 13. Global Thrombin (Human) Revenue Market Share by Region: 2015 VS 2020
Figure 14. Global Thrombin (Human) Revenue Market Share by Region: 2021 VS 2026
Figure 15. United States Thrombin (Human) Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. United States Thrombin (Human) Sales (K Units) Growth Rate (2015-2026)
Figure 17. Europe Thrombin (Human) Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. Europe Thrombin (Human) Sales (Million USD) Growth Rate (2015-2026)
Figure 19. China Thrombin (Human) Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. China Thrombin (Human) Sales (Million USD) and Growth Rate (2015-2026)
Figure 21. Japan Thrombin (Human) Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Japan Thrombin (Human) Sales (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Thrombin (Human) Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Thrombin (Human) Sales (Million USD) Growth Rate (2015-2026)
Figure 25. India Thrombin (Human) Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. India Thrombin (Human) Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Global 5 Largest Thrombin (Human) Players Market Share by Revenue in Thrombin (Human) 2015 & 2019
Figure 28. Thrombin (Human) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Thrombin (Human) Revenue Share by Type (2015-2020)
Figure 30. Global Thrombin (Human) Revenue Growth Rate by Type in 2015 & 2019
Figure 31. Global Thrombin (Human) Revenue Share by Application (2015-2020)
Figure 32. Global Thrombin (Human) Revenue Growth Rate by Application in 2015 & 2019
Figure 33. United States Thrombin (Human) Sales Market Share by Type in 2019
Figure 34. United States Thrombin (Human) Sales Market Share by Type in 2019
Figure 35. Europe Thrombin (Human) Sales Market Share by Company in 2019
Figure 36. Europe Thrombin (Human) Sales Market Share by Type in 2019
Figure 37. Europe Thrombin (Human) Sales Market Share by Application in 2019
Figure 38. China Thrombin (Human) Sales Market Share by Company in 2019
Figure 39. China Thrombin (Human) Sales Market Share by Type in 2019
Figure 40. China Thrombin (Human) Sales Market Share by Application in 2019
Figure 41. Japan Thrombin (Human) Sales Market Share by Company in 2019
Figure 42. Japan Thrombin (Human) Sales Market Share by Type in 2019
Figure 43. Japan Thrombin (Human) Sales Market Share by Application in 2019
Figure 44. Southeast Asia Thrombin (Human) Sales Market Share by Company in 2019
Figure 45. Southeast Asia Thrombin (Human) Sales Market Share by Type in 2019
Figure 46. Southeast Asia Thrombin (Human) Sales Market Share by Application in 2019
Figure 47. India Thrombin (Human) Sales Market Share by Company in 2019
Figure 48. India Thrombin (Human) Sales Market Share by Type in 2019
Figure 49. India Thrombin (Human) Sales Market Share by Application in 2019
Figure 50. Key Raw Materials Price Trend
Figure 51. Manufacturing Cost Structure of Thrombin (Human)
Figure 52. Manufacturing Process Analysis of Thrombin (Human)
Figure 53. Thrombin (Human) Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Porter's Five Forces Analysis
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
ヒト凝固因子VIIの世界市場レポート2020 Human Coagulation Factor VII is one of the proteins that cause blood to clot in the coagulation cascade. It is an enzyme of the serine protease class. It is sometimes used unlicensed in severe uncontrollable bleeding, although there have been safety concerns. A bio similar form of recombinant activa…- ヒトエンドスタチンの世界市場レポート2020 Endostatin is a naturally occurring, 20-kDa C-terminal fragment derived from type XVIII collagen. Human monomeric endostatin is a globular protein containing two disulfide bonds: Cys162−302 and Cys264−294. Market Analysis and Insights: Global Human Endostatin Market The global Human Endostatin marke…
- 組換えヒトエンドスタチンの世界市場レポート2020 Endostatin is a naturally occurring, 20-kDa C-terminal fragment derived from type XVIII collagen. Human monomeric endostatin is a globular protein containing two disulfide bonds: Cys162−302 and Cys264−294. Market Analysis and Insights: Global Recombinant Human Endostatin Market The global Recombinan…
- ヒューマンマシンインターフェース（HMI）の世界市場レポート2020 systems and humans by using HMI software or HMI panels. It helps operators interact with automated systems in vehicles and understand the plant floor automation process. HMI systems are widely adopted for plant automation purposes. They help feed in the inputs and monitor, control, and check the par…
- ヒト用予防ワクチンの世界市場レポート2020 Vaccination in the body of a healthy person causes the person to produce antibodies and obtain specific immunity in the absence of disease. For example, BCG vaccination, smallpox vaccination and so on. Market Analysis and Insights: Global Prophylactic Human Vaccine Market The global Prophylactic Hum…